CIK 0001357459
- Non-accelerated filer
- Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522007292
- Phone
- +1 858-704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-18 | Trenschel Robert J. Director | Grant or award · Stock Option (right to buy) | +48,340 | 48,340 | ||
| 2021-11-18 | Williams Donald Allen Director | Grant or award · Stock Option (right to buy) | +48,340 | 48,340 | ||
| 2021-11-18 | Neal James R Director | Grant or award · Stock Option (right to buy) | +48,340 | 48,340 | ||
| 2021-11-18 | Diaz Stephanie Director | Grant or award · Stock Option (right to buy) | +48,340 | 48,340 | ||
| 2021-11-18 | Wei Binxian Director | Grant or award · Stock Option (right to buy) | +48,340 | 48,340 | ||
| 2021-11-18 | Csimma Cristina Director | Grant or award · Stock Option (right to buy) | +48,340 | 48,340 | ||
| 2021-11-18 | GRAY MARY ANN Director | Grant or award · Stock Option (right to buy) | +48,340 | 48,340 | ||
| 2021-09-21 | Finley John David Chief Financial Officer | Purchase | +2,000 | $2.44 | $5K | 14,396 |
| 2021-09-21 | Hallam Thomas Chief Executive Officer | Purchase | +6,000 | $2.49 | $15K | 7,592 |
| 2021-09-10 | Trenschel Robert J. Director | Purchase | +2,142 | $2.98 | $6K | 14,999 |
| 2021-09-09 | Trenschel Robert J. Director | Purchase | +3,400 | $2.89 | $10K | 12,857 |
| 2021-09-08 | Trenschel Robert J. Director | Purchase | +5,000 | $2.75 | $14K | 9,457 |
| 2021-09-07 | Trenschel Robert J. Director | Purchase | +2,707 | $2.78 | $8K | 4,457 |
| 2021-08-31 | Trenschel Robert J. Director | Purchase | +1,750 | $2.75 | $5K | 1,750 |
| 2021-08-27 | Finley John David Chief Financial Officer | Purchase | +1,600 | $2.63 | $4K | 3,996 |
| 2021-08-27 | Finley John David Chief Financial Officer | Purchase | +8,400 | $2.65 | $22K | 12,396 |
| 2021-04-27 | Williams Donald Allen Director | Grant or award · Stock Option (Right to Buy) | +10,203 | 10,203 | ||
| 2021-04-27 | Williams Donald Allen Director | Grant or award · Stock Option (Right to Buy) | +4,406 | 4,406 | ||
| 2021-04-27 | Trenschel Robert J. Director | Grant or award | +304,479 | 304,479 | ||
| 2021-04-27 | Trenschel Robert J. Director | Grant or award · Stock Option (Right to Buy) | +10,182 | 10,182 |
Page 13 of 21 · 409 trades